March/April 2013

Biopharma Asia

March/April 2013 | Volume 2 Issue 2


Enabling Formulation Approaches: Considerations to advance solid dispersions into late sta...

By: Keith Horspool, Vice President Pharmaceutical Development; Chandan Bhugra, Princip...


Expectations of the US-FDA regarding dissolution data in generic drug regulatory submissio...

By: Barbara M. Davit, Director of the Division of Bioequivalence II; Ethan Stier, Depu...


Factors affecting Content Uniformity during an Active Film Coating Process for Tablets

By: Divyakant Desai, Research Fellow Bristol-Myers Squibb Company


Securing the supply chain through Rapid Screening of pharmaceutical materials

By: John Kauffman, Research Chemist; Jason Rodriguez, Chemist; Connie Gryniewicz-Ruzi...


Assessing possibilities and preventing the risk of using disposables

By: Berthold Bodeker, Chief Scientist Bayer Pharma AG


The Role of Microbial Testing in Biopharmaceutical Manufacturing

By: Tony Cundell, Senior Principal Scientist, Analytical Sciences – Microbiology M...


Making continuous processing a reality in the pharmaceutical industry

By: Mark Gibson, Associate Director, Drug Product Manufacture & Delivery; Marcel de...